Results 121 to 130 of about 60,441 (347)

Referral to and engagement in substance use disorder treatment within opioid intervention courts in New York: a qualitative study of implementation barriers and facilitators

Substance Abuse Treatment, Prevention, and Policy
Background People with opioid use disorder (OUD) are frequently in contact with the court system and have markedly higher rates of fatal opioid overdose. Opioid intervention courts (OIC) were developed to address increasing rates of opioid overdose among
Megan A. O’Grady, Katherine S. Elkington, Gail Robson, Ikenna Y. Achebe, Arthur Robin Williams, Alwyn T. Cohall, Renee Cohall, Monica Christofferson, Alejandra Garcia, Kelly S. Ramsey, Pat Lincourt, Susan Tross   +11 more
doaj   +1 more source

Prevalence of Testing for Human Immunodeficiency Virus, Hepatitis B Virus, and Hepatitis C Virus Among Medicaid Enrollees Treated With Medications for Opioid Use Disorder in 11 States, 2016–2019 [PDF]

, 2023
Katherine A. Ahrens, Michael Sharbaugh, Marian Jarlenski, Lu Tang, Lindsay Allen, Anna E. Austin, Andrew J. Barnes, Marguerite Burns, Sarah J. Clark, Kara Zivin, Aimee Mack, Gilbert C. Liu, Shamis Mohamoud, Mary Joan McDuffie, Lindsey R. Hammerslag, Adam J. Gordon, Julie M. Donohue, David Kelley, A. Everette James, Monica Costlow, Lisa Cohn, Marie LaPres, Lauryn Walker, Ashley Harrell, Kristen Voskuil, Steve Tyska, Cynthia Parsons, James T. Becker, Yilin Cai, Alyssa Brown, Alice Middleton, Cynthia Woodcock, Elizabeth R. Brown, Dara Hall, Roderick A. Rose, Emma Sandoe, Shannon Dowler, Catherine McGuire, David Jorgenson, Maik Schutze, Angela Taylor, Jeffery Talbert, Mary Applegate, Kendallyn Markman, Mark Rizzutti, Elizabeth Truex-Powell, Robert Ashmead, Emelie Bailey   +47 more
openalex   +1 more source

Chronic pain and substance use disorders among older HIV-infected sexual minority men: implications for engagement in care [PDF]

, 2018
Accepted ...
Batchelder, Abigail, Marquez, Samantha M., O'Cleirigh, Conall, Safren, Steven A., Taylor, Scott   +4 more
core  

Approved medications for opioid use disorder : current update

Expert Opinion on Pharmacotherapy
Opioid use disorder (OUD) is recognized as a chronic, relapsing disorder with a high mortality and psychiatric and somatic comorbidity.Existing guidelines and meta-analyses on pharmacotherapy of opioid use disorder were reviewed. Opioid maintenance treatment (OMT) is the generally accepted first line treatment in OUD with oral methadone and ...
openaire   +2 more sources

Research progress on the depth of anesthesia monitoring based on the electroencephalogram

Ibrain, Volume 11, Issue 1, Page 32-43, Spring 2025.
Electroencephalogram (EEG) can noninvasive, continuous, and real‐time monitor the state of brain electrical activity, and the monitoring of EEG can reflect changes in the depth of anesthesia (DOA). The development of artificial intelligence can enable anesthesiologists to extract, analyze, and quantify DOA from complex EEG data.
Xiaolan He, Tingting Li, Xiao Wang
wiley   +1 more source

Gender differences regarding interest in opioid agonist treatment with hydromorphone: a cross-sectional study of syringe service program participants

Harm Reduction Journal
Background In the United States, only 15–20% of people with opioid use disorder (OUD) receive medications for OUD annually. Injectable opioid agonist treatment with hydromorphone (iOAT-H) is a novel approach that reduces non-prescribed opioid use ...
Vitaliy Lasiychuk, Megan Ghiroli, Teresa López-Castro, Aaron D. Fox   +3 more
doaj   +1 more source

A roadmap for maximizing the use and effectiveness of recovery housing for individuals prescribed medications for opiate use disorders

Frontiers in Public Health
IntroductionSafe and stable housing is increasingly recognized as critical to recovery from alcohol and drug use disorders, but research on the outcomes of residents in recovery from opioid use disorder (OUD), particularly those prescribed medications ...
Amy A. Mericle, Carmen L. Masson, Sarah E. Zemore, Meenakshi S. Subbaraman, Dustin Khebzou, Diane Schmidt, Kwinoja Kapiteni, Leonard A. Jason   +7 more
doaj   +1 more source

Mechanisms of spinal glial activation in chemotherapy‐induced peripheral neuropathy: Focus on microglia and astrocytes

Ibrain, EarlyView.
Chemotherapy‐induced peripheral neuropathy (CIPN) remains a major clinical challenge, with central sensitization considered an important pathological mechanism in its occurrence and persistence. This review focuses on spinal astrocytes and microglia, systematically summarizing the pathological mechanisms of spinal glial cells involved in CIPN caused by
Long Gu, Song Cao, Yonghuai Feng
wiley   +1 more source

Receipt of medications for opioid use disorders among veterans by race/ethnicity and legal involvement: an observational study of electronic health records

Health & Justice
Background The Veterans Health Administration has made strides to improve access to medications for opioid use disorder overall. However, quality improvement methods to assess treatment gaps may not sufficiently detect differences in medication access by
Andrea K. Finlay, Ekaterina Pivovarova, Mengfei Yu, Christine Timko, Ingrid A. Binswanger, David Smelson, Emmeline Taylor, Alex H. S. Harris   +7 more
doaj   +1 more source

Weight change among patients engaged in medication treatment for opioid use disorder: a scoping review

, 2023
Meagan M. Carr, Raissa Lou, Grace Macdonald-Gagnon, MacKenzie R. Peltier, Melissa Funaro, Steve Martino, Robin M. Masheb   +6 more
openalex   +1 more source